Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

Similar articles for PubMed (Select 24151455)

1.

microRNAs in nociceptive circuits as predictors of future clinical applications.

Kress M, Hüttenhofer A, Landry M, Kuner R, Favereaux A, Greenberg D, Bednarik J, Heppenstall P, Kronenberg F, Malcangio M, Rittner H, Uçeyler N, Trajanoski Z, Mouritzen P, Birklein F, Sommer C, Soreq H.

Front Mol Neurosci. 2013 Oct 17;6:33. doi: 10.3389/fnmol.2013.00033. Review.

2.

MicroRNA modulation in complex regional pain syndrome.

Orlova IA, Alexander GM, Qureshi RA, Sacan A, Graziano A, Barrett JE, Schwartzman RJ, Ajit SK.

J Transl Med. 2011 Nov 10;9:195. doi: 10.1186/1479-5876-9-195.

3.

Inter- and intra-combinatorial regulation by transcription factors and microRNAs.

Zhou Y, Ferguson J, Chang JT, Kluger Y.

BMC Genomics. 2007 Oct 30;8:396.

4.

MicroRNAs regulate neuronal plasticity and are involved in pain mechanisms.

Elramah S, Landry M, Favereaux A.

Front Cell Neurosci. 2014 Feb 11;8:31. doi: 10.3389/fncel.2014.00031. eCollection 2014. Review.

5.

Differential expression of miRNAs in the nervous system of a rat model of bilateral sciatic nerve chronic constriction injury.

Li H, Shen L, Ma C, Huang Y.

Int J Mol Med. 2013 Jul;32(1):219-26. doi: 10.3892/ijmm.2013.1381. Epub 2013 May 14.

PMID:
23673427
6.

Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).

Allegra A, Alonci A, Campo S, Penna G, Petrungaro A, Gerace D, Musolino C.

Int J Oncol. 2012 Dec;41(6):1897-912. doi: 10.3892/ijo.2012.1647. Epub 2012 Oct 1. Review.

PMID:
23026890
7.

Functional analysis of neuronal microRNAs in Caenorhabditis elegans dauer formation by combinational genetics and Neuronal miRISC immunoprecipitation.

Than MT, Kudlow BA, Han M.

PLoS Genet. 2013 Jun;9(6):e1003592. doi: 10.1371/journal.pgen.1003592. Epub 2013 Jun 20.

8.

Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.

Rokah OH, Granot G, Ovcharenko A, Modai S, Pasmanik-Chor M, Toren A, Shomron N, Shpilberg O.

PLoS One. 2012;7(4):e35501. doi: 10.1371/journal.pone.0035501. Epub 2012 Apr 12.

9.

MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia.

Hua Z, Lv Q, Ye W, Wong CK, Cai G, Gu D, Ji Y, Zhao C, Wang J, Yang BB, Zhang Y.

PLoS One. 2006 Dec 27;1:e116.

10.

Spatiotemporal control of microRNA function using light-activated antagomirs.

Connelly CM, Uprety R, Hemphill J, Deiters A.

Mol Biosyst. 2012 Nov;8(11):2987-93. doi: 10.1039/c2mb25175b.

11.

Modulation of central nervous system-specific microRNA-124a alters the inflammatory response in the formalin test in mice.

Kynast KL, Russe OQ, Möser CV, Geisslinger G, Niederberger E.

Pain. 2013 Mar;154(3):368-76. doi: 10.1016/j.pain.2012.11.010. Epub 2012 Nov 24.

PMID:
23318130
12.

Genome-wide microRNA profiling of human temporal lobe epilepsy identifies modulators of the immune response.

Kan AA, van Erp S, Derijck AA, de Wit M, Hessel EV, O'Duibhir E, de Jager W, Van Rijen PC, Gosselaar PH, de Graan PN, Pasterkamp RJ.

Cell Mol Life Sci. 2012 Sep;69(18):3127-45. doi: 10.1007/s00018-012-0992-7. Epub 2012 Apr 26.

13.

The emerging role of microRNAs in the pathogenesis of systemic lupus erythematosus.

Miao CG, Yang YY, He X, Huang C, Huang Y, Zhang L, Lv XW, Jin Y, Li J.

Cell Signal. 2013 Sep;25(9):1828-36. doi: 10.1016/j.cellsig.2013.05.006. Epub 2013 May 22. Review.

PMID:
23707525
14.

Novel findings in pain processing pathways: implications for miRNAs as future therapeutic targets.

Kynast KL, Russe OQ, Geisslinger G, Niederberger E.

Expert Rev Neurother. 2013 May;13(5):515-25. doi: 10.1586/ern.13.34. Review.

PMID:
23621309
15.

microRNAs as oncogenes and tumor suppressors.

Zhang B, Pan X, Cobb GP, Anderson TA.

Dev Biol. 2007 Feb 1;302(1):1-12. Epub 2006 Aug 16. Review.

16.

microRNAs: a new emerging class of players for disease diagnostics and gene therapy.

Zhang B, Farwell MA.

J Cell Mol Med. 2008 Jan-Feb;12(1):3-21. Epub 2007 Dec 14. Review.

PMID:
18088390
17.

Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?

Gunaratne PH.

Curr Stem Cell Res Ther. 2009 Sep;4(3):168-77. Review.

PMID:
19492978
18.

Regulation of the MIR155 host gene in physiological and pathological processes.

Elton TS, Selemon H, Elton SM, Parinandi NL.

Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Review.

PMID:
23246696
19.

Pharmacological potential of RNAi--focus on miRNA.

Pfeifer A, Lehmann H.

Pharmacol Ther. 2010 Jun;126(3):217-27. doi: 10.1016/j.pharmthera.2010.03.006. Epub 2010 Apr 11. Review.

PMID:
20388525
20.

MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response.

Iborra M, Bernuzzi F, Invernizzi P, Danese S.

Autoimmun Rev. 2012 Mar;11(5):305-14. doi: 10.1016/j.autrev.2010.07.002. Epub 2010 Jul 11. Review.

PMID:
20627134
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk